Drug Trial Radar · NCT00000912
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
Last checked: Nov 19, 2026Latest source record: Oct 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
475
Actual
Start
Not stated
Primary completion
Not stated
Study completion May 2000
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare 4 different combinations of anti-HIV drugs and to determine the number of people whose HIV blood levels decrease to 200 copies/ml or less while on the treatment. This study evaluates the safety of these drug combinations, which include an experimental protease inhibitor (PI), amprenavir. Despite the success that many patients have had with PI treatment regimens, there is still a possibility that patients receiving PIs may continue to have high HIV blood levels. Because of this possibility, alternative drug combinations containing PIs are being studied. It appears that amprenavir, when taken with 3 or 4 other anti-HIV drugs, may be effective in patients with prior PI treatment experience.
Conditions
- HIV Infections
Interventions
Indinavir sulfateDrug
Abacavir sulfateDrug
AmprenavirDrug
Nelfinavir mesylateDrug
EfavirenzDrug
LevocarnitineDrug
Adefovir dipivoxilDrug
SaquinavirDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
Univ of Southern California / LA County USC Med Ctr
Los Angeles, California
USC Univ Hosp & Ambulatory Hlth Care Ctr / USC Med Ctr
Los Angeles, California
UCLA CARE Ctr
Los Angeles, California
Willow Clinic
Menlo Park, California
Univ of California / San Diego Treatment Ctr
San Diego, California
San Francisco AIDS Clinic / San Francisco Gen Hosp
San Francisco, California
San Francisco Gen Hosp
San Francisco, California
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium
San Jose, California
San Mateo AIDS Program / Stanford Univ
Stanford, California
Stanford Univ Med Ctr
Stanford, California
Univ of Colorado Health Sciences Ctr
Denver, Colorado
Howard Univ
Washington D.C., District of Columbia
Univ of Miami School of Medicine
Miami, Florida
Emory Univ
Atlanta, Georgia
Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr
Atlanta, Georgia
Queens Med Ctr
Honolulu, Hawaii
Univ of Hawaii
Honolulu, Hawaii
Tripler Army Med Ctr
Tripler AMC, Hawaii
Northwestern Univ Med School
Chicago, Illinois
Cook County Hosp
Chicago, Illinois
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois
Charity Hosp / Tulane Univ Med School
New Orleans, Louisiana
Tulane Univ School of Medicine
New Orleans, Louisiana
Johns Hopkins Hosp
Baltimore, Maryland
Harvard (Massachusetts Gen Hosp)
Boston, Massachusetts
Boston Med Ctr
Boston, Massachusetts
Univ of Minnesota
Minneapolis, Minnesota
St Louis Regional Hosp / St Louis Regional Med Ctr
St Louis, Missouri
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York
Bellevue Hosp / New York Univ Med Ctr
New York, New York
Chelsea Ctr
New York, New York
Cornell Univ Med Ctr
New York, New York
Mem Sloan - Kettering Cancer Ctr
New York, New York
Mount Sinai Med Ctr
New York, New York
Univ of Rochester Medical Center
Rochester, New York
Duke Univ Med Ctr
Durham, North Carolina
Moses H Cone Memorial Hosp
Greensboro, North Carolina
Univ of Cincinnati
Cincinnati, Ohio
Ohio State Univ Hosp Clinic
Columbus, Ohio
Milton S Hershey Med Ctr
Hershey, Pennsylvania
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.